Therefore, we hypothesized that combining anti-OX40 with CXCR4-antagonist will enhance the functionality of tumor-infiltrated effector cells as well as produce durable anti-tumor responses by augmenting immune memory. Here, TNFRSF4 is linked to neoplasm.